Comparative studies on blood serum alpha-L-fucosidases from several mammalian species.

This research focused on comparing the alpha-L-fucosidases enzymes found in the blood serum of multiple mammalian species, examining the conditions under which these enzymes are most active and how they respond to different tests.

Study Subjects and Methods

• The study encompassed multiple species of mammals, including pigs, goats, bulls, horses, and donkeys.
• The authors utilized fluorimetric and spectrophotometric procedures to determine the presence and activity of alpha-L-fucosidases. These procedures largely involve the use of fluorescent and chromogenic substances to measure biological, chemical, or physical phenomena.

Findings on Enzyme Activity

• The researchers found that alpha-L-fucosidases were generally more active when confronted with fluorescent substrates, compared to chromogenic substrates.
• The optimal pH level at which these enzymes functioned was found to be 5.5 when fluorescent substrates were used.
• However, the optima values varied when chromogenic substrates were used: it was 4.0 for goat, 4.5 for bull, 5.0 for pig, and 4.5-5.0 for horse and donkey sera.

Comparative Analysis

• It was noted through the study that pH activity profiles were very similar for two types of bulls (Morucha and Charolais) of the same species (Bos taurus L.), and also for two species within the same genus (Equus caballus and Equus asinus L.). This points towards a degree of consistency within species and genus.

Enzyme Stability

• The research found that the alpha-L-fucosidases in the serum samples were extremely heat-sensitive, becoming unstable even when subjected to a temperature of 37 degrees Celsius.

Through this study, significant findings were generated regarding the behavior of alpha-L-fucosidases in different mammalian species, their optimal conditions for action, and their stability under thermal stress. This information can prove crucial in understanding more about the functioning of these enzymes and informing future biotechnological applications or disease investigations.